Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study-Reference-Cited by-同舟云学术

Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study

Published:2017-11-21 Issue:3 Volume:19 Page:175-183
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Jao J¹,Yu W²,Patel K³,Miller TL⁴,Karalius B³,Geffner ME⁵,DiMeglio LA⁶,Mirza A⁷,Chen JS⁸,Silio M⁹,McFarland EJ¹⁰,Van Dyke RB⁹,Jacobson D²,

Affiliation:

1. Department of Obstetrics, Gynecology and Reproductive Medicine; Department of Medicine; Icahn School of Medicine at Mount Sinai; New York NY USA

2. Center for Biostatistics in AIDS Research; Harvard T. H. Chan School of Public Health; Boston MA USA

3. Department of Epidemiology; Center for Biostatistics in AIDS Research; Harvard T. H. Chan School of Public Health; Boston MA USA

4. Department of Pediatrics; University of Miami; Miami FL USA

5. Keck School of Medicine of USC; The Saban Research Institute of Children's Hospital Los Angeles; Los Angeles CA USA

6. Department of Pediatrics; Indiana University School of Medicine; Indianapolis IN USA

7. Department of Pediatrics; University of Florida College of Medicine; Jacksonville FL USA

8. Department of Pediatrics; Drexel University College of Medicine; Philadelphia PA USA

9. Department of Pediatrics; Tulane University School of Medicine; New Orleans LA USA

10. Department of Pediatrics; University of Colorado School of Medicine; Aurora CO USA

Funder

National Institute of Child Health and Human Development

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute on Drug Abuse

National Institute of Allergy and Infectious Diseases

Office of AIDS Research

National Institute of Mental Health

National Institute of Neurological Disorders and Stroke

National Institute on Deafness and Other Communication Disorders

National Heart, Lung, and Blood Institute

National Institute of Dental and Craniofacial Research

National Institute on Alcohol Abuse and Alcoholism

Tulane University

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12566/fullpdf

Reference44 articles.

1. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection;Storm;Pediatrics,2005

2. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1;Gortmaker;N Engl J Med,2001

3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study;Carr;Lancet,1999

4. Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children;Tassiopoulos;J Acquir Immune Defic Syndr,2008

5. Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study;Jacobson;Am J Clin Nutr,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy;Expert Opinion on Drug Metabolism & Toxicology;2024-08-30

2. Cardiovascular health in people with perinatally acquired HIV – where do we stand?;Current Opinion in HIV and AIDS;2024-06-27

3. Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice;Drug Design, Development and Therapy;2022-06

4. Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy;Current HIV/AIDS Reports;2021-10

5. Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy;The Lancet Child & Adolescent Health;2020-09